Skip to content

Farnesoid X Receptor (FXR) Activity in Bile Acid Metabolite Concentration (Serum/Plasma)

Published: August 9, 2026Updated: August 16, 2026

This test measures the levels of bile acids that interact with the Farnesoid X Receptor, a protein involved in regulating bile acid metabolism and liver function.

Quick summary

["Assesses how bile acids influence liver health and bile flow."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
63075-6
Short code
D farinae IgG-mCnc
Synonyms
D farinae IgG-mCnc
Category
chemistry
Sample
serum
Container
Red-top tube (SST)
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
CPT
82784
Specimen volume
5 mL
Stability
Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
Hemolysis max
500
Lipemia max
1000
Icterus max
500
TAT
4–24 hours
Order
routine

What This Test Measures

The test detects specific bile acids that bind to the Farnesoid X Receptor (FXR). These bile acids help control processes like bile production, cholesterol, and glucose metabolism in the liver. Changes in these levels may reflect how well your body is processing bile acids or could indicate liver or metabolic conditions.

Why It Might Be Ordered

Your healthcare provider may order this test if you have symptoms or conditions linked to bile acid dysfunction, such as liver disease, gallbladder issues, or metabolic disorders. It could also be part of monitoring for conditions like primary biliary cholangitis or non-alcoholic fatty liver disease.

How the Test Works

Blood is drawn to collect a serum or plasma sample. The test measures the concentration of bile acids that bind to FXR using a specialized analytical method to detect these metabolites.

Preparation for the Test

No special preparation is needed. However, inform your provider if you are taking medications that may affect bile acid levels, such as certain antibiotics or cholesterol-lowering drugs.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

Abnormal results may suggest issues with bile acid metabolism, such as liver disease, bile duct blockages, or metabolic syndrome. Elevated or altered bile acid levels could indicate conditions affecting bile flow or liver function, while different patterns might point to specific metabolic or genetic disorders.

Short name

FXR Activity Test

Frequently asked questions

What does a high or low result mean?
A high concentration of certain bile acids might indicate overproduction or improper clearance, which could be linked to liver disease or other metabolic conditions. A low concentration could suggest impaired FXR function or reduced bile acid synthesis.
Can this test be used to diagnose liver disease?
While this test can provide insight into bile acid metabolism, it is often used alongside other tests to support a diagnosis of liver or metabolic conditions. Your provider will consider the full clinical picture, including symptoms and other test results.
Does diet affect this test?
Dietary changes that significantly alter bile acid levels (e.g., very high-fat or low-fat diets) may impact results. It’s best to discuss any dietary adjustments with your healthcare provider before the test.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy